Qi Yi Luo
Director/Board Member at MICROPORT SCIENTIFIC CORPORATION
Net worth: 5 M $ as of 31/03/2024
Profile
Currently, Qi Yi Luo holds the position of Non-Executive Chairman at MicroPort CardioFlow Medtech Corp. and Chief Technology Officer of MicroPort Scientific Corp., Chairman at Shanghai MicroPort CardioFlow Medtech Co., Ltd. (a subsidiary of MicroPort Scientific Corp.). Mr. Luo is also on the board of Shanghai MicroPort EP MedTech Co., Ltd. Mr. Luo received a graduate degree from Queen's University, an undergraduate degree from Yunnan Technology & Business University and a doctorate from the University of Shanghai Science & Technology.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
30/08/2023 | 6,503,897 ( 0.35% ) | 5 M $ | 31/03/2024 |
Qi Yi Luo active positions
Companies | Position | Start |
---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Director/Board Member | 30/08/2023 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Director/Board Member | 28/04/2020 |
Former positions of Qi Yi Luo
Companies | Position | End |
---|---|---|
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Director/Board Member | 15/09/2023 |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Chairman | 29/08/2023 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Chairman | 29/08/2023 |
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Director/Board Member | 01/01/1995 |
Training of Qi Yi Luo
Queen's University | Graduate Degree |
Yunnan Technology & Business University | Undergraduate Degree |
University of Shanghai for Science & Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
Private companies | 3 |
---|---|
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Health Technology |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Qi Yi Luo